A case series of emtricitabine-induced pure red cell aplasia
Background: Anaemia is common in patients with retroviral disease. New or worsening anaemia after initiation of antiretroviral (ARV) treatment has a broad differential diagnosis. Objectives: We describe six patients who developed transfusion-dependent anaemia on first-line therapy (tenofovir, emtri...
Main Authors: | Nithendra Manickchund, Camille du Plessis, Melanie-Anne A. John, Thandekile C. Manzini, Bernadett I. Gosnell, Mahomed-Yunus S. Moosa |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2021-08-01
|
Series: | Southern African Journal of HIV Medicine |
Subjects: | |
Online Access: | https://sajhivmed.org.za/index.php/hivmed/article/view/1271 |
Similar Items
-
Emtricitabine-induced pure red cell aplasia
by: Nithendra Manickchund, et al.
Published: (2019-09-01) -
Development and validation of analytical method for quantitation of Emtricitabine, Tenofovir, Efavirenz based on HPLC
by: Arun Ramaswamy, et al.
Published: (2018-02-01) -
Pure Red Cell Aplasia Associated with Good Syndrome
by: Masayuki Okui, et al.
Published: (2017-04-01) -
Physiologically Relevant Concentrations of Dolutegravir, Emtricitabine, and Efavirenz Induce Distinct Metabolic Alterations in HeLa Epithelial and BV2 Microglial Cells
by: Joseph W. George, et al.
Published: (2021-05-01) -
Acquired pure red cell aplasia and recombinant erythropoietin
by: Somanath Padhi, et al.
Published: (2021-01-01)